ADP and thrombin rapidly increase cytosolic calcium in human platelets within 0.5 seconds under physiological flow conditions, with distinct kinetic profiles.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications for antiplatelet therapy; leaves open translation of agonist-specific calcium kinetics to human thrombosis models.
The regulation and kinetics (less than 5 seconds) of cytosolic calcium changes ([Ca2+]i) in stimulated blood platelets have been investigated under physiological blood flow conditions. Using a newly-developed continuous-flow approach with indo-1-loaded human platelets, adenosine diphosphate (ADP, 10 mumol/L) and thrombin (5 U/mL) were equally effective in significantly increasing [Ca2+]i by 0.5 seconds. ADP induced a transient [Ca2+]i peak of 1 to 2 mumol/L near 2 seconds, whereas thrombin caused a sustained and larger response. The first phase (less than 2 seconds) was not influenced by a lack of extracellular Ca2+, in contrast to the subsequent [Ca2+]i increase that only reached about 0.7 mumol/L for either ADP or thrombin. The shear rates used in our continuous-flow apparatus were physiological (less than 1,258 sec-1) and only slightly increased the basal [Ca2+]i of 0.1 mumol/L. Platelet aggregation (less than 5 seconds), assessed by single-particle counting, was not altered in platelets loaded with indo-1/AM (2.5 mumol/L).
No takes yet. Share an insight, caveat, or question.
Jones et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: